{"entity":{"type":"insider","cik":"0001691265","url":"/insider/0001691265","json_url":"/insider/0001691265.json","name":"Conner Edward R.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":18,"n_filings":18,"first":"2017-12-08","last":"2024-11-12","span_basis":"filed_date"},"name_variants":[{"name":"Conner Edward R.","source":"filing","n_filings":18,"first_seen":"2017-12-08","last_seen":"2024-11-12"}],"transactions":[{"id":2392618,"accession":"0001415889-24-026626","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-026626","line_url":"/filing/0001415889-24-026626#line-2","is_derivative":false,"issuer_cik":"0001691265","issuer_name":"Third Harmonic Bio, Inc.","issuer_ticker":"THRD","issuer_name_source":null,"issuer_url":"/issuer/0001691265","owner_cik":"0001691265","owner_name":"Conner Edward R.","owner_display_name":"Conner Edward R.","owner_url":"/insider/0001691265","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2117.0,"shares_display":"2,117","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":31755.0,"total_display":"31,755.00","total_whole":"31,755","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-08","filed_date":"2024-11-12","scope":"insider"},{"id":2156876,"accession":"0001415889-24-025750","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-025750","line_url":"/filing/0001415889-24-025750#line-2","is_derivative":false,"issuer_cik":"0001691265","issuer_name":"Third Harmonic Bio, Inc.","issuer_ticker":"THRD","issuer_name_source":null,"issuer_url":"/issuer/0001691265","owner_cik":"0001691265","owner_name":"Conner Edward R.","owner_display_name":"Conner Edward R.","owner_url":"/insider/0001691265","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2673.0,"shares_display":"2,673","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":40095.0,"total_display":"40,095.00","total_whole":"40,095","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-28","filed_date":"2024-10-30","scope":"insider"},{"id":2756703,"accession":"0001415889-24-023788","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-023788","line_url":"/filing/0001415889-24-023788#line-2","is_derivative":false,"issuer_cik":"0001691265","issuer_name":"Third Harmonic Bio, Inc.","issuer_ticker":"THRD","issuer_name_source":null,"issuer_url":"/issuer/0001691265","owner_cik":"0001691265","owner_name":"Conner Edward R.","owner_display_name":"Conner Edward R.","owner_url":"/insider/0001691265","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4790.0,"shares_display":"4,790","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":71850.0,"total_display":"71,850.00","total_whole":"71,850","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-19","filed_date":"2024-09-20","scope":"insider"},{"id":8156465,"accession":"0001209191-23-057712","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-057712","line_url":"/filing/0001209191-23-057712#line-2","is_derivative":false,"issuer_cik":"0001691265","issuer_name":"Third Harmonic Bio, Inc.","issuer_ticker":"THRD","issuer_name_source":null,"issuer_url":"/issuer/0001691265","owner_cik":"0001691265","owner_name":"Conner Edward R.","owner_display_name":"Conner Edward R.","owner_url":"/insider/0001691265","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4790.0,"shares_display":"4,790","price_per_share":10.0339,"price_display":"10.03","price_state":"stated","total_value":48062.381,"total_display":"48,062.38","total_whole":"48,062","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-05","filed_date":"2023-12-07","scope":"insider"},{"id":8723691,"accession":"0001209191-19-002871","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-002871","line_url":"/filing/0001209191-19-002871#line-2","is_derivative":false,"issuer_cik":"0001001233","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0001001233","owner_cik":"0001691265","owner_name":"Conner Edward R.","owner_display_name":"Conner Edward R.","owner_url":"/insider/0001691265","role":"Officer (Sr. VP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Sr. VP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":12.3261,"price_display":"12.33","price_state":"stated","total_value":61630.5,"total_display":"61,630.50","total_whole":"61,631","shares_owned_after":12125.0,"shares_owned_after_display":"12,125","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-07","filed_date":"2019-01-08","scope":"insider"},{"id":6267925,"accession":"0001209191-18-061668","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-061668","line_url":"/filing/0001209191-18-061668#line-2","is_derivative":false,"issuer_cik":"0001001233","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0001001233","owner_cik":"0001691265","owner_name":"Conner Edward R.","owner_display_name":"Conner Edward R.","owner_url":"/insider/0001691265","role":"Officer (Sr. VP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Sr. VP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":11.4866,"price_display":"11.49","price_state":"stated","total_value":57433.0,"total_display":"57,433.00","total_whole":"57,433","shares_owned_after":12125.0,"shares_owned_after_display":"12,125","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-06","filed_date":"2018-12-07","scope":"insider"},{"id":6635372,"accession":"0001209191-18-057677","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-057677","line_url":"/filing/0001209191-18-057677#line-2","is_derivative":false,"issuer_cik":"0001001233","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0001001233","owner_cik":"0001691265","owner_name":"Conner Edward R.","owner_display_name":"Conner Edward R.","owner_url":"/insider/0001691265","role":"Officer (Sr. VP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Sr. VP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":13.73,"price_display":"13.73","price_state":"stated","total_value":68650.0,"total_display":"68,650.00","total_whole":"68,650","shares_owned_after":12125.0,"shares_owned_after_display":"12,125","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-06","filed_date":"2018-11-07","scope":"insider"},{"id":6202312,"accession":"0001209191-18-054573","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-054573","line_url":"/filing/0001209191-18-054573#line-2","is_derivative":false,"issuer_cik":"0001001233","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0001001233","owner_cik":"0001691265","owner_name":"Conner Edward R.","owner_display_name":"Conner Edward R.","owner_url":"/insider/0001691265","role":"Officer (Sr. VP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Sr. VP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":14.5547,"price_display":"14.55","price_state":"stated","total_value":72773.5,"total_display":"72,773.50","total_whole":"72,774","shares_owned_after":10125.0,"shares_owned_after_display":"10,125","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-08","filed_date":"2018-10-09","scope":"insider"},{"id":6337300,"accession":"0001209191-18-050085","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-050085","line_url":"/filing/0001209191-18-050085#line-2","is_derivative":false,"issuer_cik":"0001001233","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0001001233","owner_cik":"0001691265","owner_name":"Conner Edward R.","owner_display_name":"Conner Edward R.","owner_url":"/insider/0001691265","role":"Officer (Sr. VP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Sr. VP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":14.169,"price_display":"14.17","price_state":"stated","total_value":70845.0,"total_display":"70,845.00","total_whole":"70,845","shares_owned_after":10125.0,"shares_owned_after_display":"10,125","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-06","filed_date":"2018-09-07","scope":"insider"},{"id":6020557,"accession":"0001209191-18-045758","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-045758","line_url":"/filing/0001209191-18-045758#line-2","is_derivative":false,"issuer_cik":"0001001233","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0001001233","owner_cik":"0001691265","owner_name":"Conner Edward R.","owner_display_name":"Conner Edward R.","owner_url":"/insider/0001691265","role":"Officer (Sr. VP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Sr. VP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":13.45,"price_display":"13.45","price_state":"stated","total_value":67250.0,"total_display":"67,250.00","total_whole":"67,250","shares_owned_after":10125.0,"shares_owned_after_display":"10,125","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-06","filed_date":"2018-08-07","scope":"insider"},{"id":6559049,"accession":"0001209191-18-042044","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-042044","line_url":"/filing/0001209191-18-042044#line-2","is_derivative":false,"issuer_cik":"0001001233","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0001001233","owner_cik":"0001691265","owner_name":"Conner Edward R.","owner_display_name":"Conner Edward R.","owner_url":"/insider/0001691265","role":"Officer (Sr. VP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Sr. VP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":15.795,"price_display":"15.80","price_state":"stated","total_value":78975.0,"total_display":"78,975.00","total_whole":"78,975","shares_owned_after":10125.0,"shares_owned_after_display":"10,125","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-06","filed_date":"2018-07-09","scope":"insider"},{"id":6078705,"accession":"0001209191-18-036325","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-036325","line_url":"/filing/0001209191-18-036325#line-2","is_derivative":false,"issuer_cik":"0001001233","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0001001233","owner_cik":"0001691265","owner_name":"Conner Edward R.","owner_display_name":"Conner Edward R.","owner_url":"/insider/0001691265","role":"Officer (Sr. VP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Sr. VP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":16.67,"price_display":"16.67","price_state":"stated","total_value":83350.0,"total_display":"83,350.00","total_whole":"83,350","shares_owned_after":10125.0,"shares_owned_after_display":"10,125","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-06","filed_date":"2018-06-07","scope":"insider"},{"id":6291187,"accession":"0001209191-18-028954","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-028954","line_url":"/filing/0001209191-18-028954#line-2","is_derivative":false,"issuer_cik":"0001001233","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0001001233","owner_cik":"0001691265","owner_name":"Conner Edward R.","owner_display_name":"Conner Edward R.","owner_url":"/insider/0001691265","role":"Officer (Sr. VP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Sr. VP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":16.3628,"price_display":"16.36","price_state":"stated","total_value":81814.0,"total_display":"81,814.00","total_whole":"81,814","shares_owned_after":10125.0,"shares_owned_after_display":"10,125","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-07","filed_date":"2018-05-09","scope":"insider"},{"id":6725008,"accession":"0001209191-18-024422","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-024422","line_url":"/filing/0001209191-18-024422#line-2","is_derivative":false,"issuer_cik":"0001001233","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0001001233","owner_cik":"0001691265","owner_name":"Conner Edward R.","owner_display_name":"Conner Edward R.","owner_url":"/insider/0001691265","role":"Officer (Sr. VP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Sr. VP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":17.413,"price_display":"17.41","price_state":"stated","total_value":87065.0,"total_display":"87,065.00","total_whole":"87,065","shares_owned_after":8125.0,"shares_owned_after_display":"8,125","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-06","filed_date":"2018-04-09","scope":"insider"},{"id":6043032,"accession":"0001209191-18-017884","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-017884","line_url":"/filing/0001209191-18-017884#line-2","is_derivative":false,"issuer_cik":"0001001233","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0001001233","owner_cik":"0001691265","owner_name":"Conner Edward R.","owner_display_name":"Conner Edward R.","owner_url":"/insider/0001691265","role":"Officer (Sr. VP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Sr. VP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":24.7755,"price_display":"24.78","price_state":"stated","total_value":123877.5,"total_display":"123,877.50","total_whole":"123,878","shares_owned_after":8125.0,"shares_owned_after_display":"8,125","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-06","filed_date":"2018-03-07","scope":"insider"},{"id":6583115,"accession":"0001209191-18-008165","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-008165","line_url":"/filing/0001209191-18-008165#line-2","is_derivative":false,"issuer_cik":"0001001233","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0001001233","owner_cik":"0001691265","owner_name":"Conner Edward R.","owner_display_name":"Conner Edward R.","owner_url":"/insider/0001691265","role":"Officer (Sr. VP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Sr. VP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":18.4871,"price_display":"18.49","price_state":"stated","total_value":92435.5,"total_display":"92,435.50","total_whole":"92,436","shares_owned_after":8125.0,"shares_owned_after_display":"8,125","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-06","filed_date":"2018-02-07","scope":"insider"},{"id":6041700,"accession":"0001209191-18-003159","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-003159","line_url":"/filing/0001209191-18-003159#line-2","is_derivative":false,"issuer_cik":"0001001233","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0001001233","owner_cik":"0001691265","owner_name":"Conner Edward R.","owner_display_name":"Conner Edward R.","owner_url":"/insider/0001691265","role":"Officer (Sr. VP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Sr. VP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":17.109,"price_display":"17.11","price_state":"stated","total_value":85545.0,"total_display":"85,545.00","total_whole":"85,545","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-08","filed_date":"2018-01-10","scope":"insider"},{"id":4273762,"accession":"0001209191-17-064858","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-064858","line_url":"/filing/0001209191-17-064858#line-2","is_derivative":false,"issuer_cik":"0001001233","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0001001233","owner_cik":"0001691265","owner_name":"Conner Edward R.","owner_display_name":"Conner Edward R.","owner_url":"/insider/0001691265","role":"Officer (Sr. VP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Sr. VP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":16.24,"price_display":"16.24","price_state":"stated","total_value":81200.0,"total_display":"81,200.00","total_whole":"81,200","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-06","filed_date":"2017-12-08","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":18,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":18,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":18},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001923840","name":"Third Harmonic Bio, Inc.","url":"/issuer/0001923840","role":"Officer (Chief Medical Officer)","n_filings":4,"first_seen":"2023-12-07","last_seen":"2024-11-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001001233","name":"SANGAMO THERAPEUTICS, INC","url":"/issuer/0001001233","role":"Officer (Sr. VP & Chief Medical Officer)","n_filings":14,"first_seen":"2017-12-08","last_seen":"2019-01-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001691265","retrieved_at":"2026-08-24T20:32:12+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}